Novo CEO pressed by Senate to cut charges of weight problems, diabetic issues medicines CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers about the record costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. Don't https://zionaqgxm.pointblog.net/everything-about-healthcare-news-72635740